Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Hot Flashes 2Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Prostatic Neoplasms 1Head and Neck Neoplasms 1Depression 1Breast Neoplasms 1

Interventions

Venlafaxine Hydrochloride 2Sodium Chloride 2Magnesium Oxide 2Gabapentin 2Bupivacaine 2fezolinetant 1black cohosh root extract 1bazedoxifene 1Tamoxifen 1Soybean Proteins 1Solifenacin Succinate 1Isoflavones 1Hypericum extract LI 160 1Estrogens, Conjugated (USP) 1Estetrol 1Daptomycin 1Clonidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Hot Flashes × Venlafaxine Hydrochloride × Clear all
NCT01533753 2019-11-21

Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer

University of Wisconsin, Madison

Phase 2 Terminated
5 enrolled 5 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT00198250 2008-11-14

Venlafaxine for Hot Flashes After Breast Cancer

Indiana University

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡